BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10456929)

  • 1. Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis.
    Manoutcharian K; Terrazas LI; Gevorkian G; Acero G; Petrossian P; Rodriguez M; Govezensky T
    Infect Immun; 1999 Sep; 67(9):4764-70. PubMed ID: 10456929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.
    Toledo A; Larralde C; Fragoso G; Gevorkian G; Manoutcharian K; Hernández M; Acero G; Rosas G; López-Casillas F; Garfias CK; Vázquez R; Terrazas I; Sciutto E
    Infect Immun; 1999 May; 67(5):2522-30. PubMed ID: 10225916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraspleen DNA inoculation elicits protective cellular immune responses.
    Cano A; Fragoso G; Gevorkian G; Terrazas LI; Petrossian P; Govezensky T; Sciutto E; Manoutcharian K
    DNA Cell Biol; 2001 Apr; 20(4):215-21. PubMed ID: 11403718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response.
    Toledo A; Fragoso G; Rosas G; Hernández M; Gevorkian G; López-Casillas F; Hernández B; Acero G; Huerta M; Larralde C; Sciutto E
    Infect Immun; 2001 Mar; 69(3):1766-73. PubMed ID: 11179354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity against Taenia crassiceps murine cysticercosis induced by DNA vaccination with a Taenia saginata tegument antigen.
    Rosas G; Fragoso G; Garate T; Hernández B; Ferrero P; Foster-Cuevas M; Parkhouse RM; Harrison LJ; Briones SL; González LM; Sciutto E
    Microbes Infect; 2002 Nov; 4(14):1417-26. PubMed ID: 12475632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis.
    Manoutcharian K; Díaz-Orea A; Gevorkian G; Fragoso G; Acero G; González E; De Aluja A; Villalobos N; Gómez-Conde E; Sciutto E
    Vet Immunol Immunopathol; 2004 May; 99(1-2):11-24. PubMed ID: 15113650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium.
    Wu L; Diao Z; Deng X; Gao J; Zhou Z; Liu Y; Wang Y
    J Nanosci Nanotechnol; 2005 Aug; 5(8):1204-10. PubMed ID: 16193978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.
    NoeDominguez-Romero A; Zamora-Alvarado R; Servín-Blanco R; Pérez-Hernández EG; Castrillon-Rivera LE; Munguia ME; Acero G; Govezensky T; Gevorkian G; Manoutcharian K
    Hum Vaccin Immunother; 2014; 10(11):3201-13. PubMed ID: 25483665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against Taenia crassiceps cysticercosis: identification of the most promising antigens in the induction of protective immunity.
    Valdez F; Hernández M; Govezensky T; Fragoso G; Sciutto E
    J Parasitol; 1994 Dec; 80(6):931-6. PubMed ID: 7799166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic papaya: a useful platform for oral vaccines.
    Fragoso G; Hernández M; Cervantes-Torres J; Ramírez-Aquino R; Chapula H; Villalobos N; Segura-Velázquez R; Figueroa A; Flores I; Jiménez H; Adalid L; Rosas G; Galvez L; Pezzat E; Monreal-Escalante E; Rosales-Mendoza S; Vazquez LG; Sciutto E
    Planta; 2017 May; 245(5):1037-1048. PubMed ID: 28194565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mimotope-based antigens as potential vaccine candidates in experimental murine cysticercosis.
    Manhani MN; Tilelli CQ; Ribeiro VDS; Goulart LR; Costa-Cruz JM
    Parasitology; 2020 Oct; 147(12):1330-1337. PubMed ID: 32660680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysticercosis vaccine: cross protecting immunity with T. solium antigens against experimental murine T. crassiceps cysticercosis.
    Sciutto E; Fragoso G; Trueba L; Lemus D; Montoya RM; Diaz ML; Govezensky T; Lomeli C; Tapia G; Larralde C
    Parasite Immunol; 1990 Nov; 12(6):687-96. PubMed ID: 2084611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from murine cysticercosis by immunization with a parasite cysteine protease.
    Baig S; Damian RT; Morales-Montor J; Ghaleb A; Baghdadi A; White AC
    Microbes Infect; 2006 Oct; 8(12-13):2733-5. PubMed ID: 16979365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the S3Pvac vaccine against murine Taenia crassiceps cysticercosis: a historical review.
    Sciutto E; Fragoso G; Hernández M; Rosas G; Martínez JJ; Fleury A; Cervantes J; Aluja A; Larralde C
    J Parasitol; 2013 Aug; 99(4):693-702. PubMed ID: 23409920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic DNA vaccination: unexpected increased resistance against murine cysticercosis induced by non-specific enhanced immunity.
    Cruz-Revilla C; Sonabend AM; Rosas G; Toledo A; Meneses G; Lopez-Casillas F; Hernández B; Fragoso G; Sciutto E
    J Parasitol; 2006 Jun; 92(3):655-7. PubMed ID: 16884018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide contributes to host resistance against experimental Taenia crassiceps cysticercosis.
    Alonso-Trujillo J; Rivera-Montoya I; Rodríguez-Sosa M; Terrazas LI
    Parasitol Res; 2007 May; 100(6):1341-50. PubMed ID: 17206501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taenia crassiceps cysticercosis: protective effect and immune response elicited by DNA immunization.
    Cruz-Revilla C; Rosas G; Fragoso G; López-Casillas F; Toledo A; Larralde C; Sciutto E
    J Parasitol; 2000 Feb; 86(1):67-74. PubMed ID: 10701566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taenia solium and Taenia ovis: stage-specific expression of the vaccine antigen genes, TSOL18, TSOL16, and homologues, in oncospheres.
    Gauci CG; Verástegui MR; Gilman RH; Lightowlers MW
    Exp Parasitol; 2006 Aug; 113(4):272-5. PubMed ID: 16510142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosis.
    Vázquez-Talavera J; Solís CF; Terrazas LI; Laclette JP
    Infect Immun; 2001 Sep; 69(9):5412-6. PubMed ID: 11500411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses and epitope specificities to the Taenia solium cysticercosis vaccines TSOL18 and TSOL45-1A.
    Kyngdon CT; Gauci CG; Gonzalez AE; Flisser A; Zoli A; Read AJ; Martínez-Ocaña J; Strugnell RA; Lightowlers MW
    Parasite Immunol; 2006 May; 28(5):191-9. PubMed ID: 16629704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.